Credit Suisse Ag Abiomed Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.0 - $381.3 $0 - $135 Million	-352,926 Reduced 99.71%	1,035 $0
Q3 2022 Nov 10, 2022	SELL	$242.49 - $301.46 $5.42 Million - $6.73 Million	-22,337 Reduced 5.94%	353,961 $87 Million
Q2 2022 Aug 12, 2022	SELL	$224.73 - $338.64 $10.2 Million - $15.4 Million	-45,595 Reduced 10.81%	376,298 $93.1 Million
Q1 2022 May 16, 2022	SELL	$277.25 - $366.29 $58.5 Million - $77.3 Million	-211,031 Reduced 33.34%	421,893 $140 Million
Q4 2021 Feb 14, 2022	SELL	$300.63 - $371.35 $32.6 Million - $40.3 Million	-108,522 Reduced 14.64%	632,924 $227 Million
Q3 2021 Nov 12, 2021	SELL	$310.19 - $376.2 $34.5 Million - $41.9 Million	-111,340 Reduced 13.06%	741,446 $241 Million
Q2 2021 Aug 16, 2021	SELL	$262.71 - $351.17 $14 Million - $18.7 Million	-53,204 Reduced 5.87%	852,786 $266 Million
Q1 2021 May 14, 2021	BUY	$285.92 - $355.13 $61.9 Million - $76.9 Million	216,404 Added 31.38%	905,990 $289 Million
Q4 2020 Feb 12, 2021	BUY	$251.88 - $324.2 $11.3 Million - $14.6 Million	44,979 Added 6.98%	689,586 $224 Million
Q3 2020 Nov 13, 2020	SELL	$255.22 - $317.0 $20.1 Million - $24.9 Million	-78,622 Reduced 10.87%	644,607 $179 Million
Q2 2020 Aug 12, 2020	SELL	$141.4 - $257.09 $4.22 Million - $7.67 Million	-29,835 Reduced 3.96%	723,229 $175 Million
Q1 2020 May 13, 2020	BUY	$130.51 - $196.01 $18.3 Million - $27.5 Million	140,097 Added 22.86%	753,064 $109 Million
Q4 2019 Feb 12, 2020	BUY	$159.31 - $223.54 $56.2 Million - $78.8 Million	352,578 Added 135.4%	612,967 $105 Million
Q3 2019 Nov 12, 2019	BUY	$175.89 - $279.23 $9.91 Million - $15.7 Million	56,323 Added 27.6%	260,389 $46.3 Million
Q2 2019 Aug 14, 2019	BUY	$250.96 - $284.94 $3.52 Million - $3.99 Million	14,018 Added 7.38%	204,066 $53.2 Million
Q1 2019 May 14, 2019	BUY	$276.39 - $362.25 $3.85 Million - $5.04 Million	13,919 Added 7.9%	190,048 $54.3 Million
Q4 2018 Feb 13, 2019	BUY	$281.08 - $444.25 $12.2 Million - $19.3 Million	43,405 Added 32.7%	176,129 $57.2 Million
Q3 2018 Nov 13, 2018	BUY	$354.53 - $449.75 $10.5 Million - $13.3 Million	29,503 Added 28.58%	132,724 $59.7 Million
Q2 2018 Aug 14, 2018	BUY	$278.07 - $446.21 $14.7 Million - $23.6 Million	52,891 Added 105.09%	103,221 $42.2 Million
Q1 2018 May 15, 2018	SELL	$192.49 - $295.85 $851,383 - $1.31 Million	-4,423 Reduced 8.08%	50,330 $14.6 Million
Q4 2017 Feb 14, 2018	BUY	$168.78 - $199.74 $1.66 Million - $1.97 Million	9,845 Added 21.92%	54,753 $10.3 Million
Q3 2017 Nov 14, 2017	SELL	$145.39 - $168.6 $2.87 Million - $3.33 Million	-19,733 Reduced 30.53%	44,908 $7.57 Million
Q2 2017 Aug 14, 2017	BUY	N/A	64,641	64,641 $9.26 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account